SCHEMBL5745528

SCHEMBL5745528

Nc1ccnc(C=O)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29953193 1.00 — —
SCHEMBL27552624 0.83 S1PR4 (0.34) —
SCHEMBL13117471 0.77 — —
SCHEMBL29026954 0.77 LOXL2 (0.52) —
SCHEMBL7609085 0.76 ERN1 (0.38) —
SCHEMBL986987 0.74 ALDH1A1 (0.38) —
SCHEMBL12519534 0.74 ALDH1A1 (0.47) —
SCHEMBL24766044 0.73 — —
SCHEMBL1094456 0.73 — —
SCHEMBL5700538 0.73 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2931044-B1 PROCESSES FOR THE PREPARATION OF 4-AMINO-3-HALO-6- (SUBSTITUTED)PICOLINATES AND 4-AMINO-5-FLUORO-3-HALO-6- (SUBSTITUTED)PICOLINATES DOW AGROSCIENCES LLC (US) 2017-07-05 — — EP claimed
US-9433622-B2 Pyrimidine compounds useful in the treatment of diseases mediated by IKKE and/or TBK1 mechanisms CASE WESTERN RESERVE UNIVERSITY (US) 2016-09-06 — — US disclosed
US-9433622-B2 Pyrimidine compounds useful in the treatment of diseases mediated by IKKE and/or TBK1 mechanisms CASE WESTERN RESERVE UNIVERSITY (US) 2016-09-06 — — US disclosed
EP-2958910-B1 PYRIMIDINE COMPOUNDS USEFUL IN THE TREATMENT OF DISEASES MEDIATED BY IKKE AND/OR TBK1 MECHANISMS DOMAINEX LTD (GB) 2016-08-03 — — EP disclosed
US-20160000784-A1 PYRIMIDINE COMPOUNDS USEFUL IN THE TREATMENT OF DISEASES MEDIATED BY IKKE AND/OR TBK1 MECHANISMS DOMAINEX LIMITED (GB) 2016-01-07 — — US disclosed
US-20160000784-A1 PYRIMIDINE COMPOUNDS USEFUL IN THE TREATMENT OF DISEASES MEDIATED BY IKKE AND/OR TBK1 MECHANISMS DOMAINEX LIMITED (GB) 2016-01-07 — — US disclosed
WO-2014128486-A1 PYRIMIDINE COMPOUNDS USEFUL IN THE TREATMENT OF DISEASES MEDIATED BY IKKE AND/OR TBK1 MECHANISMS DOMAINEX LIMITED (GB) 2014-08-28 — — WO disclosed
CN-101172993-A 2'-c-methyl-3'-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections CENTRE NAT RECH SCIENT (KY) 2008-05-07 — — CN disclosed
US-20060293503-A1 Polyaminopyridines and method for producing same SUMITOMO SEIKA CHEMICALS CO., LTD (JP) 2006-12-28 — — US disclosed
EP-1669390-A1 POLYAMINOPYRIDINES AND METHOD FOR PRODUCING SAME SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) 2006-06-14 — — EP disclosed
CN-1678326-A 2 '-C-methyl-3' -O-L-valine ester ribofuranosyl cytidine for treatment of flavivirus infections IDENIX CAYMAN LTD (KY) 2005-10-05 — — CN disclosed
CN-1322197-A Novel 4-amino-1-arylpyridin-2-ones having anticonvulsant activity and process for preparing same DRESDEN ARZNEIMITTEL (DE) 2001-11-14 — — CN disclosed
Send feedback